14575-59-8 Usage
Description
1-phenyl-1H-1,2,4-triazole-3,5-diamine is a chemical compound with the molecular formula C9H9N5. It is a white to light yellow solid with a molecular weight of 179.20 g/mol. This versatile compound is characterized by its triazole ring structure and amino groups, which contribute to its diverse applications across various industries.
Uses
Used in Pharmaceutical Industry:
1-phenyl-1H-1,2,4-triazole-3,5-diamine is used as an active pharmaceutical ingredient for the development of drugs targeting various health conditions. Its unique chemical structure allows it to interact with biological targets, making it a promising candidate for medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, 1-phenyl-1H-1,2,4-triazole-3,5-diamine is used as a triazole fungicide, herbicide, and antifungal agent. Its ability to control and prevent the growth of unwanted organisms in agricultural settings contributes to increased crop yields and protection against diseases.
Used in Organic Synthesis:
1-phenyl-1H-1,2,4-triazole-3,5-diamine serves as a building block and reagent in organic synthesis. Its functional groups and structural features make it a valuable component in the creation of various organic compounds, including dyes, pigments, and other specialty chemicals.
Used in Dye and Pigment Production:
As an intermediate in the production of dyes and pigments, 1-phenyl-1H-1,2,4-triazole-3,5-diamine contributes to the development of colorants for a wide range of applications, such as textiles, plastics, and printing inks. Its chemical properties enable the creation of stable and vibrant colorants.
Used in Anticancer and Anti-tumor Research:
1-phenyl-1H-1,2,4-triazole-3,5-diamine has demonstrated potential anti-cancer and anti-tumor properties, making it a subject of interest for researchers in the field of oncology. Its ability to target and inhibit the growth of cancer cells could lead to the development of novel therapeutic agents for cancer treatment.
Overall, 1-phenyl-1H-1,2,4-triazole-3,5-diamine is a multifaceted compound with applications spanning pharmaceuticals, agrochemicals, organic synthesis, dye and pigment production, and cancer research. Its versatility and potential for further development make it an important chemical entity in various scientific and industrial domains.
Check Digit Verification of cas no
The CAS Registry Mumber 14575-59-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,5,7 and 5 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 14575-59:
(7*1)+(6*4)+(5*5)+(4*7)+(3*5)+(2*5)+(1*9)=118
118 % 10 = 8
So 14575-59-8 is a valid CAS Registry Number.
InChI:InChI=1/C8H9N5/c9-7-11-8(10)13(12-7)6-4-2-1-3-5-6/h1-5H,(H4,9,10,11,12)
14575-59-8Relevant articles and documents
Concise and regiospecific syntheses of tri-substituted 1,2,4-triazoles
Dunstan, Andrew R.,Weber, Hans-Peter,Rihs, Grety,Widmer, Hans,Dziadulewicz, Edward K.
, p. 7983 - 7986 (1998)
Novel tri-substituted 1,2,4-triazoles are synthesized via complementary, regiospecific routes as part of a lead finding exercise. A key feature of one of the syntheses is recognition of an intrinsic regioselectivity toward deprotonation in the 1-phenylguanazole substrate.
ASYMMETRIC TRIAZOLE BENZAMIDE DERIVATIVES AND THE COMPOSITIONS AND METHODS OF TREATMENT REGARDING THE SAME
-
Paragraph 681; 682, (2019/06/17)
The present disclosure is directed to asymmetric triazole benzamide compounds of formula (I) and formula (II), pharmaceutical compositions thereof and methods for modulating or activating a Parkin ligase The present disclosure is also directed to methods of treating and/or reducing the incidence of diseases or conditions related to the activation of Parkin ligase. R1, R2, R3, M1, M2, M3, L1, L2, and L3 are as defined herein.
TRIAZOLE BENZAMIDE DERIVATIVES AND THE COMPOSITIONS AND METHODS OF TREATMENT REGARDING THE SAME
-
Paragraph 570; 571, (2018/01/17)
The present disclosure is directed to triazole benzamide compounds of formula (I) and formula (II), pharmaceutical compositions thereof and methods for modulating or activating a Parkin ligase The present disclosure is also directed to methods of treating and/or reducing the incidence of diseases or conditions related to the activation of Parkin ligase. R1, R2, R3, M1, M2, M3, L1, L2, and L3 are as defined herein.